The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Evaluation of factors associated with glucocorticoid‐induced osteopenia in patients with rheumatic diseases
Abstract
In 161 ambulatory rheumatic disease patients receiving long‐term prednisone therapy, diaphyseal mass (DM) and metaphyseal mass (MM) of the forearm were measured by single photon absorptiometry, and bone radiographs were reviewed when available. Multivariate analysis of treatment and patient characteristics demonstrated that glucocorticoid‐induced osteopenia (defined as an elevated DM:MM ratio) and bone fractures occurred with similar frequency in patients of each sex, in whites and blacks, in patients with various rheumatic diseases, and in patients receiving different regimens of prednisone therapy. However, large cumulative doses of prednisone were associated with elevated DM:MM ratios as well as with bone fractures, and menopause or age ⩾ 50 years (males or females) was associated with bone fractures. We conclude that longterm therapy with various prednisone regimens results in glucocorticoid‐induced osteopenia and fractures. This affect is cumulative, occurs in all patient groups, and results in more bone fractures in certain groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
STEINBROCKER, O. (1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900430001001 · Cited by 2,877
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A. D., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 674
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O'Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 659
Menopausal Estrogen Therapy and Hip Fractures
PAGANINI-HILL, A., ROSS, R. K., GERKINS, V. R., HENDERSON, B. E., ARTHUR, M., & MACK, T. M. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-1-28 · Cited by 468
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
Seeman, E., Wahner, H. W., Offord, K. P., Kumar, R., Johnson, W. J., & Riggs, B. L. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110570 · Cited by 463
Hahn, T. J., Halstead, L. R., Teitelbaum, S. L., & Hahn, B. H. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109506 · Cited by 399
Self-citationPrecision and Accuracy of Bone Mineral Determination by Direct Photon Absorptiometry
Cameron, J. R., Mazess, R. B., & Sorenson, J. A. (1968) · Investigative Radiology · doi:10.1097/00004424-196805000-00001 · Cited by 369
Intestinal Calcium Absorption in Exogenous Hypercortisonism
Klein, R. G., Arnaud, S. B., Gallagher, J. C., Deluca, H. F., & Riggs, B. L. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108762 · Cited by 362
Bone loss in adults receiving alternate day glucocorticoid therapy
Gluck, O. S., Murphy, W. A., Hahn, T. J., & Hahn, B. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240705 · Cited by 197
Self-citationOsteoporosis of rheumatoid arthritis: Influence of age, sex and corticosteroids
Saville, P. D., & Kharmosh, O. (1967) · Arthritis & Rheumatism · doi:10.1002/art.1780100504 · Cited by 158
Cited by
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
“[104] reported that younger people are more susceptible than the elderly, but other studies reported an absence of age effect [35,61,66,101].”
InfluentialGlucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,066
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Rheumatology · doi:10.1093/rheumatology/39.12.1383 · Cited by 696
Roubenoff, R., Roubenoff, R. A., Cannon, J. G., Kehayias, J. J., Zhuang, H., Dawson-Hughes, B., Dinarello, C. A., & Rosenberg, I. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117244 · Cited by 584
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
“Two smaller studies demonstrated that the cumulative (compared with daily) GC dose was the stronger predictor of fracture (8,9).”
BackgroundSaag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Epidemiology of Vertebral Fractures
Schousboe, J. T. (2016) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2015.08.004 · Cited by 451
Bone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Oral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Lodder, M. C., de Jong, Z., Kostense, P. J., Molenaar, E. T. H., Staal, K., Voskuyl, A. E., Hazes, J. M. W., Dijkmans, B. A. C., & Lems, W. F. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016253 · Cited by 202
“Some previous reports did find an association between corticosteroid use and low BMD, 16 28 whereas others, 13 29 including our main analyses, did not.”
Ishida, Y., & Heersche, J. N. M. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.12.1822 · Cited by 155
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
Eastell, R., Devogelaer, J.-P., Peel, N. F. A., Chines, A. A., Bax, D. E., Sacco-Gibson, N., Nagant de Deuxchaisnes, C., & Russell, R. G. G. (2000) · Osteoporosis International · doi:10.1007/s001980070122 · Cited by 134
Gronowicz, G. A., & McCarthy, M. B. (1995) · Endocrinology · doi:10.1210/endo.136.2.7530648 · Cited by 87
Li, X., Liang, T., Dai, B., Chang, L., Zhang, Y., Hu, S., Guo, J., Xu, S., Zheng, L., Yao, H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci166795 · Cited by 41
Bone safety of low-dose glucocorticoids in rheumatic diseases
Saag, K. G. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12446 · Cited by 15
Metadata
- Authors
- Dykman, T. R., Gluck, O. S., Murphy, W. A., Hahn, T. J., & Hahn, B. H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1985-04
- Volume
- 28
- Issue
- 4
- Pages
- 361-368
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2168928820
- Cited by
- 281
- References
- 17
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.